HALEON PLC SPON ADS

HLN05 Dec 2024
Healthcare
$9.71
0.00 (-0.10%)
Lowest Today
$9.69
Highest Today
$9.76
Today’s Open
$9.71
Prev. Close
$9.71
52 Week High
$10.8
52 Week Low
$7.83
To Invest in HALEON PLC SPON ADS

HALEON PLC SPON ADS

Healthcare
HLN05 Dec 2024
0.00 (-0.10%)
1M
3M
6M
1Y
5Y
Low
$9.68
Day’s Range
High
$9.76
9.68
52 Week Low
$7.83
52-Week Range
52 Week High
$10.8
7.83
1 Day
-
1 Week
-0.2%
1 month return
-0.56%
3 month return
-5.59%
6 month return
+15.87%
1 Year return
+14.63%
3 Years return
-
5 Years return
-
10 Years return
-
Institutional Holdings
Dodge & Cox
3.96
Dodge & Cox Stock I
2.88
FMR Inc
2.32
ClearBridge Advisors, LLC
0.83
Harding Loevner L.P.
0.55
Dodge & Cox Balanced Composite
0.33
Dodge & Cox Balanced I
0.33

Market Status

Fundamentals
Market Cap
43722.72 mln
PB Ratio
2.07
PE Ratio
28.44
Enterprise Value
53561.15 mln
Total Assets
34055 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Organisation
HALEON PLC SPON ADS
Employees
25408
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Brian James McNamara
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step